Companies ›Consumer Non Cyclicals ›NWND.ST

NWND.ST — Nasdaq Stockholm Food Processing

New Nordic Healthbrands AB

kr16,10

Open in Charts → Attach watcher ⌖

— —

SEK

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

1,55 %

Op margin

2,6 %

ROE

7,9 %

Net margin

1,4 %

Debt / equity

0,35

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

New Nordic Healthbrands AB maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.35, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.6, suggesting it can cover its short-term obligations but with limited buffer. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its short-term liquidity. In terms of profitability, the company's return on equity (ROE) is 7.92%, and its return on assets (ROA) is 3.33%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating returns at a level that would be considered robust by industry standards. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher risk if demand in its primary market fluctuates. The company's growth trajectory appears to be modest, with limited data available on year-over-year revenue cha

Business. New Nordic Healthbrands AB (NWND.ST) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Beverages

IndustryFood Processing

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

7,9 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning NWND.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to NWND.ST. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

New Nordic Healthbrands AB (NWND.ST) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Beverages

IndustryFood Processing

AI synthesis

GENERATED

In terms of profitability, the company's return on equity (ROE) is 7.92%, and its return on assets (ROA) is 3.33%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating returns at a level that would be considered robust by industry standards.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher risk if demand in its primary market fluctuates.

The company's growth trajectory appears to be modest, with limited data available on year-over-year revenue changes. The operating cash flow of 8.39 million SEK and free cash flow of 7.19 million SEK suggest the company is generating positive cash from operations, but the capital expenditure of -3.47 million SEK indicates some investment in maintaining or expanding its operations.

The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position being negative after subtracting total debt is a key flag, indicating potential liquidity constraints. The dilution risk is low, with no significant dilution potential reported in the basic shares outstanding.

Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial statements and disclosures do not mention any significant new projects, partnerships, or regulatory changes that would impact its near-term performance.

Key takeaways

New Nordic Healthbrands AB has a moderate debt-to-equity ratio of 0.35, indicating a balanced capital structure.
The company's ROE of 7.92% and ROA of 3.33% are below industry benchmarks, suggesting suboptimal returns.
The company's liquidity position is medium, with a current ratio of 1.6 and a negative net cash position after debt.
The company's revenue is concentrated in a single segment, increasing exposure to market fluctuations.
The company's growth trajectory is modest, with positive operating and free cash flows but limited capital expenditure.
The company faces medium liquidity risk and low dilution risk, with no significant dilution potential reported.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

kr16,10

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

kr103.5M

Net cashⓘ

-kr19.3M

Current ratioⓘ

1.6

Debt / equityⓘ

0.3

ROAⓘ

3.3%

ROEⓘ

7.9%

Cash conversionⓘ

102.0%

CapEx / revenueⓘ

-0.6%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin2,6 %Below median

Net Margin1,4 %Below median

ROE7,9 %Above median

Capex / Rev-0,6 %Above P75

D/E0,35Below median

Cash Conv1,02Above median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

New Nordic Healthbrands AB Market data — financials · 2026-05-28

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

NWND.STCanonical

Nasdaq Stockholm · SEK

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread